Santiago G Borrego, PhD
@santi14borrego
Followers
304
Following
2K
Media
108
Statuses
580
Postdoctoral Fellow at @HopkinsMedicine @sandra_misale lab Amateur Runner: - 10K (41:06) - 21K (1:33:20) - 42K (3:25:26) 🏡 Llion
Baltimore, MD
Joined September 2021
This is a nightmare. Half of Leon and Zamora is burning right now...
Hoy ha sido un día realmente duro. Nuestras actuaciones se han centrado en defender la localidad de #Castrocalbón #León #IFMolezuelasDeLaCarballeda Os dejamos unos 📽 de la actuaciones que hemos llevado a cabo. #BuenasNoches y mucho ánimo a tod@s los afectad@s.
0
0
0
My heart is broken right now 💔
0
0
1
So proud of the amazing @santi14borrego presenting our work at #AACR25! Misale lab is rocking in Chicago! @AACR @HopkinsMedicine @KRASKickers @CD_AACR #proudPI
1
3
44
We're hiring! 🚨 Exciting #Postdoc opportunity to lead a project on #flea #biology and #microbe #interactions, in the PYP team at the @ciilofficiel🧬🦠 🔬Profile: PhD in Biology, Immunology, or related. 📆 Start: June-July 2025 (up to 3 years) Apply now! #VBD #PostdocJobs #Plague
1
70
117
Fresh out of press! 🧬🔬We are happy to share our latest work published in @CancerDiscovery! https://t.co/sbNgJyDDz9 A thread🧵 Please, Enjoy and share! #CancerResearch, #PrecisionOncology #CancerTherapeutics
2
6
41
More on RAS targeting! Our stellar postdoc Tessa Seale presented her project on RAS blockade in AML and CMML at #AACR25. Hematological malignancies are also frequently driven by mutant RAS,we hope to develop RAS targeting in these settings.Great job,Tessa!@AACR @HopkinsMedicine
1
2
30
So proud of presenting our most recent results today at ##AACR25! Fantastic major symposium on KRAS targeting with legends Frank Mccormick and Piro Lito! @AACR @KRASKickers @hopkinskimmel @HopkinsMedicine
4
6
87
🚨Really happy to share our newest study about the different signalling in RAS G12 and RAS Q61 tumors. Tomorrow from 2-5 pm I'll be presenting my poster regarding this study (Section 17, Board 3), please come to visit @AACR @Sandra_Misale @HopkinsMedicine @hopkinskimmel @CD_AACR
Online now concurrent with the #AACR25 oral presentation by Cancer Discovery Early Career Award Winner @Sandra_Misale: Direct Inhibition of RAS Reveals the Features of Oncogenic Signaling Driven by RAS G12 and Q61 Mutations https://t.co/0hwAJj17rF
0
1
12
Piro Lito and Sandra Misale with Frank McCormick! The Godfather of RAS and the future Godfather and Godmother of RAS!@MSKCancerCenter @JohnHopkins @MDAndersonNews #AACR25!
3
4
23
Thank you @CD_AACR and @AACR for this incredible honor! I'm grateful to everyone at @HopkinsMedicine, @hopkinskimmel, and my amazing colleagues for their support. Congratulations to all fellow awardees of AACR journals - together, we advance #CancerResearch. 🎉 #AACR25
Congratulations to @Sandra_Misale, PhD, recipient of the 2025 Cancer Discovery Early Career Award, which recognizes the outstanding contributions of #earlycareer investigators. Learn more: https://t.co/pBdtwVAKZu
#AACR25 @HopkinsMedicine @hopkinskimmel @AACR
34
24
374
Hello early researchers! Interesting in doing a PhD in senescence, ageing and cancer. We have an open position in our lab in Spain! Please retweet or reach out if interested!
0
24
27
I'm very please to present our latest work on NF1-null melanoma! Check it out!
Exciting research alert! Our team’s and @Rosenlab1 latest study dives deep into #melanoma, specifically NF1-mutant melanoma: highly aggressive with limited targeted therapies. We identified potential strategies to better tackle this challenging cancer. https://t.co/ocLX0Aq6U0.
0
0
4
In the November issue of @CD_AACR @Sandra_Misale @hopkinskimmel has written a spotlight on the four (!) KRAS related papers in this issue: https://t.co/XXxiJ9OARF Find them here 👇🏽
aacrjournals.org
Summary:. In this issue, four articles highlight the critical role of nongenetic mechanisms and cell plasticity in mediating resistance to different classes of RAS inhibitors in pancreatic ductal...
2
14
37
Our final #BreastCancer topic this month is risk reduction. Risk reduction is actions that can be taken to reduce the risk or chance of developing a disease. Check out the image for 4 ways to reduce your risk!
0
4
7
Wonderful first day #ENAsymp24 and exciting session on KRAS targeting with @cjder23, @norbertkraut1, and Jayesh Desai. This is really the best time for KRAS research, I'm proud to give our contribution too! @KRASKickers @hopkinskimmel @HopkinsMedicine
1
3
42
📌Highlights from the 5th RAS Initiative Symposium at the @FredNatLab! Researchers gathered to enhance collaboration in targeting RAS-driven cancers. Read more about the discussions and innovations that emerged from this impactful event: https://t.co/w7GerFPgsk
@theNCI
0
1
22